1,316
Views
7
CrossRef citations to date
0
Altmetric
Articles

Serum levels of MMP-7 in primary brain cancers and brain metastases

, , , , , , & show all
Pages 881-885 | Received 27 Nov 2018, Accepted 28 May 2019, Published online: 10 Jun 2019

Figures & data

Figure 1. MMP-7 serum levels in non-tumour brain diseаses, benign brain cancers and brain metastases compared to controls.

Note: The data are presented as mean values with standard error of the mean (±SEM). *p = 0.006 controls versus benign brain tumours; **p = 0.0001 controls versus brain metastases.

Figure 1. MMP-7 serum levels in non-tumour brain diseаses, benign brain cancers and brain metastases compared to controls.Note: The data are presented as mean values with standard error of the mean (±SEM). *p = 0.006 controls versus benign brain tumours; **p = 0.0001 controls versus brain metastases.

Figure 2. MMP-7 serum levels in GBM patients compared to other brain tumours and controls.

Note: The data are presented as mean values with standard error of the mean (±SEM). *p = 0.018 glioblastoma versus benign brain tumours; **p = 0.001 glioblastoma versus brain metastases.

Figure 2. MMP-7 serum levels in GBM patients compared to other brain tumours and controls.Note: The data are presented as mean values with standard error of the mean (±SEM). *p = 0.018 glioblastoma versus benign brain tumours; **p = 0.001 glioblastoma versus brain metastases.

Figure 3. MMP-7 serum levels in samples (n = 7) collected before and after surgery of patients with GBM and brain metastases.

Note: The data are presented as mean values with standard error of the mean (±SEM).

Figure 3. MMP-7 serum levels in samples (n = 7) collected before and after surgery of patients with GBM and brain metastases.Note: The data are presented as mean values with standard error of the mean (±SEM).